MGNX/ 04/08/2026 · 5:42 PM MacroGenics’ LINNET Trial Back on Track After FDA Removes Partial Hold FDA lifted hold on MacroGenics’ cancer study. New patients can join again; drug helps immune system fight tough ovarian cancers.
